Risk of hepatitis B exacerbation is low after transcatheter arterial chemoembolization therapy for patients with HBV-related hepatocellular carcinoma: report of a prospective study.
作者： Joong-Won Park , Kyung Woo Park , Sang Hyung Cho , Hong Suk Park , Woo Jin Lee
DOI: 10.1111/J.1572-0241.2005.00232.X
关键词:
摘要: Risk of Hepatitis B Exacerbation is Low After Transcatheter Arterial Chemoembolization Therapy for Patients with HBV-related Hepatocellular Carcinoma: Report a Prospective Study
nature.com
sci-hub.se 参考文章(31)
M Fidler-Jenko, M Vovk, S Markovic, G Drozina, Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients. Hepato-gastroenterology. ,vol. 46, pp. 2925- 2930 ,(1999)
Anna S.F. Lok, Raymond H.S. Liang, Edmond K.W. Chiu, Kee-Lam Wong, Tai-Kwong Chan, David Todd, Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy Gastroenterology. ,vol. 100, pp. 182- 188 ,(1991) , 10.1016/0016-5085(91)90599-G
Winnie Yeo, Paul K.S. Chan, Sheng Zhong, Wing M. Ho, Joyce L. Steinberg, John S. Tam, Pun Hui, Nancy W.Y. Leung, Benny Zee, Philip J. Johnson, Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors Journal of Medical Virology. ,vol. 62, pp. 299- 307 ,(2000) , 10.1002/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0
S M Lemon, K Nishioka, S Mishiro, L Johnson, The 18th United States‐Japan Joint Hepatitis Panel Meeting Hepatology. ,vol. 25, pp. 1287- 1291 ,(1997) , 10.1002/HEP.510250542
Akihiro Tamori, Shuhei Nishiguchi, Motoharu Tanaka, Hiroko Kurooka, Shunsuke Fujimoto, Kenji Nakamura, Susumu Shiomi, Lamivudine therapy for hepatitis B virus reactivation in a patient receiving intra-arterial chemotherapy for advanced hepatocellular carcinoma. Hepatology Research. ,vol. 26, pp. 77- 80 ,(2003) , 10.1016/S1386-6346(03)00002-0
Giuseppe Rossi, Annamaria Pelizzari, Maddalena Motta, Massimo Puoti, Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy British Journal of Haematology. ,vol. 115, pp. 58- 62 ,(2001) , 10.1046/J.1365-2141.2001.03099.X
Andres T. Blei, The impact of Hepatology. Hepatology. ,vol. 39, pp. 1- 1 ,(2004) , 10.1002/HEP.20008
Yun-Fan Liaw, Joseph JY Sung, Wan Cheng Chow, Geoffrey Farrell, Cha-Ze Lee, Hon Yuen, Tawesak Tanwandee, Qi-Min Tao, Kelly Shue, Oliver N Keene, Jonathan S Dixon, D Fraser Gray, Jan Sabbat, None, Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease The New England Journal of Medicine. ,vol. 351, pp. 1521- 1531 ,(2004) , 10.1056/NEJMOA033364
Tak Mao Chan, Guo Xiang Fang, Colin S. O. Tang, Ignatius K. P. Cheng, Kar Neng Lai, Stephen K. N. Ho, Preemptive lamivudine therapy based on HBV DNA level in HBsAg‐positive kidney allograft recipients Hepatology. ,vol. 36, pp. 1246- 1252 ,(2002) , 10.1053/JHEP.2002.36156
Giovan B. Vizzini, Angelo Luca, Ignazio R. Marino, Hepatitis B Virus Reactivation after a Single Session of Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Annals of Internal Medicine. ,vol. 138, pp. 691- 692 ,(2003) , 10.7326/0003-4819-138-8-200304150-00036